Annual Drug Patent Expirations for FENSOLVI+KIT
Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.
Drug patent litigation for FENSOLVI KIT.
This drug has fifty-nine patent family members in twenty-six countries.
The generic ingredient in FENSOLVI KIT is leuprolide acetate. Two suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
